ESVS Guidelines: Section A--prevention in patients with carotid stenosis
| Autor: | Liapis, CD, Bell, PF, Mikhailidis, DP, Sivenius, J, Nicolaides, A, Fernandes e. Fernandes, J, Norgren, L, Avgerinos, ED, Becker, F, Benedetti Valentini, F, Bequemin, JP, Diener, HC, Gaines, PA, Gensini, G, Gerotziafas, G, Griffin, M, Hacke, W, Heikkinen, MA, Norrving, B, Powell, J, Kakisis, J, Karkos, C, Konstantinidis, K, Kotsis, T, Mätzsch, T, Parsson, H, Pedro, LM, Salenius, JP, Schachter, M, Sillesen, H, Thomas, DJ, BIASI, GIORGIO MARIA, FROIO, ALBERTO, LAVITRANO, MARIALUISA |
|---|---|
| Přispěvatelé: | Liapis, C, Bell, P, Mikhailidis, D, Sivenius, J, Nicolaides, A, Fernandes e. Fernandes, J, Biasi, G, Norgren, L, Avgerinos, E, Becker, F, Benedetti Valentini, F, Bequemin, J, Diener, H, Froio, A, Gaines, P, Gensini, G, Gerotziafas, G, Griffin, M, Hacke, W, Heikkinen, M, Norrving, B, Powell, J, Kakisis, J, Karkos, C, Konstantinidis, K, Kotsis, T, Lavitrano, M, Mätzsch, T, Parsson, H, Pedro, L, Salenius, J, Schachter, M, Sillesen, H, Thomas, D |
| Rok vydání: | 2010 |
| Předmět: |
Adult
medicine.medical_specialty Placebo-controlled study Carotid Stenosi law.invention Randomized controlled trial law Risk Factors Carotid artery disease Internal medicine medicine Humans Carotid Stenosis cardiovascular diseases Antihypertensive Agents Hypolipidemic Agents Pharmacology Hypolipidemic Agent biology business.industry Platelet Aggregation Inhibitor Risk Factor Contraindications C-reactive protein Cholesterol LDL Vascular surgery medicine.disease Clinical trial Stenosis Antihypertensive Agent Cerebrovascular Disorders Cerebrovascular Disorder Cardiology biology.protein Platelet aggregation inhibitor Drug Therapy Combination Drug Monitoring Cardiology and Cardiovascular Medicine business Platelet Aggregation Inhibitors |
| Zdroj: | Current vascular pharmacology. 8(5) |
| ISSN: | 1875-6212 |
| Popis: | Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|